Deutsches Herzzentrum Muenchen: Coronary Artery Disease trials

The registry lists 26 Coronary Artery Disease studies with Deutsches Herzzentrum Muenchen as lead sponsor. 2 are open to participants now and 0 have results posted.

Phase 2 1Phase 3 1Phase 4 20No phase 4(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Intracoronary Stenting and Additional Results Achieved by ShockWAVE Coronary LithotripsyRecruitingNCT06369142Not applicable
• Intracoronary Stenting and Restenosis - Randomized Trial of Drug-eluting Stent Implantation or Drug-coated Balloon Angioplasty According to Neointima Morphology in Drug-eluting Stent Restenosis 5RecruitingNCT05544864Not applicable
• NIRS-IVUS to Improve Assessment of Coronary Artery Disease Severity in Patients Referred for Transcatheter Aortic Valve ImplantationStatus unknownNCT04976062
• A ComparIson of Strategies to PrepAre SeveRely CALCified Coronary LesionsCompletedNCT03487432Not applicable
• Intracoronary Stenting and Antithrombotic Regimen: Lesion Platelet Adhesion as Selective Target of Endovenous RevaceptCompletedNCT03312855Phase 2
• Study Comparing Ticagrelor With Aspirin for Prevention of Vascular Events in Patients Undergoing CABGTerminatedNCT01755520Phase 3
• ORSIRO Stents Versus Xience PRIME Stents Assessed by Optical Coherence TomographyCompletedNCT01594736Phase 4
• Intracoronary Stenting and Antithrombotic Regimen: ADjusting Antiplatelet Treatment in PatienTs Based on Platelet Function TestingStatus unknownNCT01456364Phase 4
• Prospective Randomized Trial On Radiation Dose Estimates Of CT Angiography In Patients Applying Iterative Image Reconstruction Techniques - The PROTECTION V Study -Status unknownNCT01453712Phase 4
• Instrumental Sealing of Arterial Puncture Site Closure Device Versus Manual Compression TrialCompletedNCT01389375Phase 4
• Impact of Dabigatran and Phenprocoumon on Clopidogrel Mediated ADP Induced Platelet Aggregation in Patients With Atrial FibrillationTerminatedNCT01352702Phase 4
• Test of Long-Term Safety and Efficacy of Sirolimus-Permanent-Polymer Eluting Stent (Cypher)- and Sirolimus-Polymer-free Eluting Stents (PPS/PFS) Assessed by Optical Coherence TomographyStatus unknownNCT01260558Phase 4
• Test Safety and Efficacy of Zotarolimus- and Everolimus-Eluting Stents (ZES/EES) Assessed by Optical Coherence TomographyStatus unknownNCT01230723Phase 4
• Test Safety of Biodegradable and Permanent Limus-Eluting Stents Assessed by Optical Coherence TomographyCompletedNCT01097434Phase 4
• Test Efficacy of Biodegradable and Permanent Limus-Eluting StentsStatus unknownNCT01068106Phase 4
• Triple Therapy in Patients on Oral Anticoagulation After Drug Eluting Stent ImplantationStatus unknownNCT00776633Phase 4
• Zotarolimus and Everolimus-Eluting Stents ProsPectively Compared in Real WorldStatus unknownNCT00768846Phase 4
• Reduced Dose of Unfractionated Heparin in Patients Undergoing PCICompletedNCT00735280Phase 4
• Safety and Efficacy of Six Months Dual Antiplatelet Therapy After Drug-Eluting StentingStatus unknownNCT00661206Phase 4
• Abrupt Versus Tapered Interruption of Chronic Clopidogrel Therapy After DES ImplantationTerminatedNCT00640679Phase 4
• Efficacy Study of Two Different Strategies for Restenosis in Sirolimus-Eluting StentsCompletedNCT00598715Phase 4
• 3 Limus Agent Eluting Stents With Different Polymer CoatingCompletedNCT00598676Phase 4
• Rapamycin+Estradiol- vs. Rapamycin-Eluting Stents to Reduce Restenosis (ISAR-PEACE)CompletedNCT00402636Phase 4
• Iodixanol vs. Iomeprol to Prevent Contrast-Induced Nephropathy After Coronary Intervention (CONTRAST)CompletedNCT00390585Phase 4
• Rapamycin-Eluting Stents With Different Polymer Coating to Reduce Restenosis (ISAR-TEST-3)CompletedNCT00350454Phase 4
• Un-fractionated Heparin Versus Bivalirudin During Percutaneous Coronary Interventions (PCI) (ISAR-REACT-3)CompletedNCT00262054Phase 4